Arranta Bio

About:

Arranta Bio is a superior Contract Development Manufacturing Organization.

Website: http://arrantabio.com/

Top Investors: Ampersand Capital Partners

Description:

Arranta Bio was formed in May 2019 with the vision to be the best-in-class microbiome CDMO, developing and manufacturing live biotherapeutic products (LBPs) for pioneers targeting diseases linked to the microbiome, using bacterial fermentation, isolation, drying and encapsulation. In October 2019, we completed an $82,000,000 funding round with sole institutional investor, Ampersand Capital, company founders and colleagues, and a strategic investment from Thermo Fisher Scientific.

Total Funding Amount:

$82M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2019-01-01

Contact Email:

info(AT)arrantabio.com

Founders:

Iain Baird, Mark Bamforth

Number of Employees:

51-100

Last Funding Date:

2021-03-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai